Who Ordered That? The Economics of Treatment Choices in Medical Care

Handbook of Health Economics

Volumn 2, Issue , 2011, Pages 397-432

  Chandra, Amitabh ^a   Cutler, David ^a   Song, Zirui ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

Behavioral economics; Decision making; Demand heterogeneity; Income; Payment systems; Preferences; Specialization; Supply side incentives; Variations

Indexed keywords

EID: 83255192330     PISSN: 15740064     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53592-4.00006-2     Document Type: Chapter

References (151)

1. Abelson, R. (2006). Heart procedure is off the charts in an Ohio City. New York Times, August 18.
2. Akl E.A., Oxman A.D., Herrin J., Vist G.E., Terrenato I., Sperati F., et al. Using alternative statistical formats for presenting risks and risk reductions. Cochrane Database of Systematic Reviews 2011, 3:CD006776.
3. American College of Cardiology Foundation, Appropriate Use Criteria Task Force, et al. Appropriate use criteria for echocardiography. Journal of the American College of Cardiology 2011, 57(9):1126-1166.
4. American Joint Committee on Cancer AJCC cancer staging manual 2010, Springer, Inc., New York. 7th ed.
5. Angus D.C., Barnato A.E., Linde-Swirble W.T., et al. Use of intensive care at the end of life in the United States: An epidemiologic study. Critical Care Medicine 2004, 32:638-643.
6. Anthony D.L., Brooke Herndon M., Gallagher P.M., Barnato A.E., Bynum J.P.W., Gottlieb D.J., et al. How much do patients' preferences contribute to resource use?. Health Affairs 2009, 28(3):864-873.
7. Arrow K.J. Uncertainty and the welfare economics of medical care. American Economic Review 1963, 53:941-973.
8. Atkins D., Best D., Briss P.A., Eccles M., Falck-Ytter Y., Flottorp S., et al. Grading quality of evidence and strength of recommendations. BMJ 2004, 328(7454):1490.
9. Back A.L., Young J.P., McCown E., et al. Abandonment at the end of life from patient, caregiver, nurse, and physician perspectives: Loss of continuity and lack of closure. Archives of Internal Medicine 2009, 169(5):474-479.
10. Baicker, K. & Chandra, A. (2004). Medicare spending, the physician workforce, and beneficiaries' quality of care. Health Affairs (Millwood), Suppl. Web Exclusives: W4-184-97.
11. Baicker, K., Chandra, A., Skinner, J. S., & Wennberg, J. E. (2004). Who you are and where you live: How race and geography affect the treatment of Medicare beneficiaries. Health Affairs (Millwood), Suppl. Variation: VAR33-44.
12. Baicker K., Fisher E.S., Chandra A. Malpractice liability costs and the practice of medicine in the Medicare program. Health Affairs 2007, 26(3, May-June):841-852.
13. Barry M.J., Fowler F.J., Mulley A.G., Henderson J.V., Wennberg J.E. Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Medical Care 1995, 33(8):771-782.
14. Bertrand M., Mullainathan S., Shafir E. A behavioral-economics view of poverty. American Economic Review 2004, 94(2):419-423.
15. Berwick D.M. Quality of health care. Part 5: Payment by capitation and the quality of care. New England Journal of Medicine 1996, 335(16):1227-1231.
16. Bill-Axelson A., Holmberg L., Ruutu M., Häggman M., Andersson S.O., Bratell S., et al. Radical prostatectomy versus watchful waiting in early prostate cancer. New England Journal of Medicine 2005, 352(19):1977-1984.
17. Birkmeyer J.D., Siewers A.E., Finlayson E.V., et al. Hospital volume and surgical mortality in the United States. New England Journal of Medicine 2002, 346:1128-1137.
18. Boden W.E., O'Rourke R.A., Teo K.K., et al. Optimal medical therapy with or without PCI for stable coronary disease. New England Journal of Medicine 2007, 356(15):1503-1516.
19. Bolla M., Gonzalez D., Warde P., Dubois J.B., Mirimanoff R.O., Storme G., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. New England Journal of Medicine 1997, 337(5):295-300.
20. Botti S., Iyengar S.S. The dark side of choice: When choice impairs social welfare. Journal of Public Policy and Marketing 2006, 25(1):24-38.
21. Brennan T.A., Leape L.L., Laird N.M., Hebert L., Localio A.R., Lawthers A.G., et al. Incidence of adverse events and negligence in hospitalized patients: Results of the Harvard Medical Practice Study I. 1991. Quality & Safety in Health Care 2004, 13(2):145-151.
22. Buntin M.B., Haviland A.M., McDevitt R., Sood N. Healthcare spending and preventive care in high-deductible and consumer-directed health plans. American Journal of Management Care 2011, 17(3):222-230.
23. Caffrey A.R., Quilliam B.J., LaPlante K.L. Comparative effectiveness of linezolid and vancomycin among a national cohort of patients infected with methicillin-resistant Staphylococcus aureus. Antimicrobial Agents Chemotherapy 2010, 54(10):4394-4400.
24. Campbell E.G., Regan S., Gruen R.L., Ferris T.G., Rao S.R., Cleary P.D., et al. Professionalism in medicine: Results of a national survey of physicians. Annals of Internal Medicine 2007, 147(11):795-802.
25. Campbell E.G., Weissman J.S., Ehringhaus S., Rao S.R., Moy B., Feibelmann S., et al. Institutional academic industry relationships. JAMA 2007, 298(15):1779-1786.
26. Cassel C.K., Reuben D.B. Specialization, subspecialization, and subsubspecialization in internal medicine. New England Journal of Medicine 2011, 364(12):1169-1173.
27. Chandra, A. & Skinner, J. S. (2011). Technology growth and expenditure growth in health care. NBER Working Paper 16953.
28. Chandra A., Staiger D.O. Productivity spillovers in health care: Evidence from the treatment of heart attacks. Journal of Political Economy 2007, 115(1):103-140.
29. Chandra A., Gruber J., McKnight R. Patient cost-sharing and hospitalization offsets in the elderly. American Economic Review 2010, 100(1):193-213.
30. Choudhry N.K., Anderson G.M., Laupacis A., Ross-Degnan D., Normand S.L., Soumerai S.B. Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: Matched pair analysis. BMJ 2006, 332(7534):141-145.
31. Cooper R.A. Weighing the evidence for expanding physician supply. Annals of Internal Medicine 2004, 141(9):705-714.
32. Cooperberg M.R., Broering J.M., Kantoff P.W., Carroll P.R. Contemporary trends in low risk prostate cancer: Risk assessment and treatment. Journal of Urology 2007, 178(3 Pt 2):S14-S19.
33. Coulam, R. F. & Gaumer, G. L. (1991). Medicare's prospective payment system: A critical appraisal. Health Care Financing Review, Annual Supplement, 45-77.
34. Cromwell J., Mitchell J.B. Physician-induced demand for surgery. Journal of Health Economics 1986, 5:293-313.
35. Cutler, D. M. (2004). Your money or your life: Strong medicine for America's healthcare system. Oxford University Press.
36. Dahm P., Yeung L.L., Chang S.S., Cookson M.S. A critical review of clinical practice guidelines for the management of clinically localized prostate cancer. Journal of Urology 2008, 180(2):451-459.
37. Dale W., Bilir S.P., Hemmerich J., Basu A., Elstein A., Meltzer D. The prevalence, correlates, and impact of logically inconsistent preferences in utility assessments for joint health states in prostate cancer. Medical Care 2011, 49(1):59-66.
38. Doyle J.J., Ewer S.M., Wagner T.H. Returns to physician human capital: Evidence from patients randomized to physician teams. Journal of Health Economics 2010, 29(6):866-882.
39. Dranove D., Wehner P. Physician-induced demand for childbirths. Journal of Health Economics 1994, 13:61-73.
40. Drazer M.W., Huo D., Schonberg M.A., Razmaria A., Eggener S.E. Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States. Journal of Clinical Oncology 2011, 29(13):1736-1743.
41. Dudley R.A., Johansen K.L., Brand R., Rennie D.J., Milstein A. Selective referral to high-volume hospitals: Estimating potentially avoidable deaths. JAMA 2000, 283:1159-1166.
42. Ellis R.P., McGuire T.G. Provider behavior under prospective reimbursement. Journal of Health Economics 1986, 5:129-151.
43. Ellis R.P., McGuire T.G. Supply-side and demand-side cost sharing in health care. Journal of Economic Perspectives 1993, 7(4):135-151.
44. Epstein A.J., Nicholson S. The formation and evolution of physician treatment styles: An application to cesarean sections. Journal of Health Economics 2009, 28(6):1126-1240.
45. Fagerlin, A. & Schneider, C. E. (2004). Enough: The failure of the living will. Hastings Center Report, 34, 30-42.
46. Fehr E., Gächter S. Fairness and retaliation: The economics of reciprocity. Journal of Economic Perspectives 2000, 14(3):159-181.
47. Feldman R., Sloan F. Competition among physicians, revisited. Journal of Health Politics, Policy and Law 1988, 13:239-261.
48. Finks J.F., Osborne N.H., Birkmeyer J.D. Trends in hospital volume and operative mortality for high-risk surgery. New England Journal of Medicine 2011, 364(22):2128-2137.
49. Fisher, E. S., Bell, J., Tomek, I. M., Esty, A. R., & Goodman, D. C. (2010). Trends and regional variation in hip, knee, and shoulder replacement. The Dartmouth Institute for Health Policy and Clinical Practice, April 6.
50. Fisher E.S., Wennberg D.E., Stukel T.A., Gottlieb D.J., Lucas F.L., Pinder E.L. The implications of regional variations in Medicare spending. Part 1: The content, quality, and accessibility of care. Annals of Internal Medicine 2003, 138(4):273-287.
51. Fisher E.S., Wennberg D.E., Stukel T.A., Gottlieb D.J., Lucas F.L., Pinder E.L. The implications of regional variations in Medicare spending. Part 2: Health outcomes and satisfaction with care. Annals of Internal Medicine 2003, 138(4):288-298.
52. Frank R.G., Zeckhauser R.J. Custom-made versus ready-to-wear treatments: Behavioral propensities in physicians' choices. Journal of Health Economics 2007, 26(6):1101-1127.
53. Fuchs V.R. The supply of surgeons and the demand for operations. Journal of Human Resources 1978, XIII:35-56.
54. Gawande, A. (2009). The cost conundrum: What a Texas town can teach us all about health care. The New Yorker, June 1.
55. Gibbons R. Incentives in organizations. Journal of Economic Perspectives 1998, 12(4):115-132.
56. Gibbons R. Four formal(izable) theories of the firm?. Journal of Economic Behavior & Organization 2005, 58:200-245.
57. Glover J.A. The incidence of tonsillectomy in children. Proceeding of the Royal Society of Medicine 1938, 31:1219-1236.
58. Goldman D., Philipson T.J. Integrated insurance design in the presence of multiple medical technologies. American Economic Review 2007, 97(2):427-432.
59. Groopman, J. (2007). How doctors think. New York: Houghton Mifflin.
60. Gruber J., Owings M. Physician financial incentives and Cesarean section delivery. RAND Journal of Economics 1996, 27:99-123.
61. Halpern D.F. Critical thinking across the curriculum: A brief edition of thought and knowledge 1987, Lawrence Erlbaum Associates, p. 194.
62. Hampson L.A., Agrawal M., Joffe S., Gross C.P., Verter J., Emanuel E.J. Patients' views on financial conflicts of interest in cancer research trials. New England Journal of Medicine 2006, 355(22):2330-2337.
63. Harris J.E. The internal organization of hospitals: Some economic implications. Bell Journal of Economics 1977, 8(2):467-482.
64. Hart O., Holmstrom B. A theory of firm scope. Quarterly Journal of Economics 2010, CXXV(2):483-513.
65. Hayes J.H., Ollendorf D.A., Pearson S.D., Barry M.J., Kantoff P.W., Stewart S.T., et al. Active surveillance compared with initial treatment for men with low-risk prostate cancer: A decision analysis. JAMA 2010, 304(21):2373-2380.
66. Hodgkin D., McGuire T.G. Payment levels and hospital response to prospective payment. Journal of Health Economics 1994, 13(1):1-29.
67. Holmstrom B., Roberts J. The boundaries of the firm revisited. Journal of Economic Perspectives 1998, 12(4):73-94.
68. SEER cancer statistics review, 1975-2008 2011, National Cancer Institute, Bethesda, MD. N. Howlader, A.M. Noone, M. Krapcho, N. Neyman, R. Aminou, W. Waldron (Eds.).
69. Hsu J., Price M., Huang J., Brand R., Fung V., Hui R., et al. Unintended consequences of caps on Medicare drug benefits. New England Journal of Medicine 2006, 354(22):2349-2359.
70. Huskamp H.A., Deverka P.A., Epstein A.M., Epstein R.S., McGuigan K.A., Frank R.G. The effect of incentive-based formularies on prescription-drug utilization and spending. New England Journal of Medicine 2003, 349(23):2224-2232.
71. Iyengar S.S., Lepper M.R. When choice is demotivating: Can one desire too much of a good thing?. Journal of Personality and Social Psychology 2000, 79(6):995-1006.
72. Jacobson M., Earle C.C., Price M., Newhouse J.P. How Medicare's payment cuts for cancer chemotherapy drugs changed patterns of treatment. Health Affairs (Millwood) 2010, 29(7):1391-1399.
73. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics, 2009. CA Cancer Journal for Clinicians 2009, 59(4):225-249.
74. Joyce G.F., Escarce J.J., Solomon M.D., Goldman D.P. Employer drug benefit plans and spending on prescription drugs. JAMA 2002, 288(14):1733-1739.
75. Kahneman D., Knetsch J.L., Thaler R.H. Anomalies: The endowment effect, loss aversion, and status quo bias. Journal of Economic Perspectives 1991, 5(1):193-206.
76. Kolata, G. (2010). Results unproven, robotic surgery wins converts. The New York Times, February 13.
77. Kozower, B. D. & Stukenborg, G. J. (2011). The relationship between hospital lung cancer resection volume and patient mortality risk: study design: original observational research (population based cohort study). Annals of Surgery [Epub ahead of print].
78. Law M.R., Majumdar S.R., Soumerai S.B. Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: Controlled longitudinal study. BMJ 2008, 337:a1055.
79. Lee D.H., Vielemeyer O. Analysis of overall level of evidence behind Infectious Diseases Society of America practice guidelines. Archives of Internal Medicine 2011, 171(1):18-22.
80. Leigh J.P., Tancredi D., Jerant A., Kravitz R.L. Physician wages across specialties: Informing the physician reimbursement debate. Archives of Internal Medicine 2010, 170(19):1728-1734.
81. Lichtenstein S., Slovic P., Fischhoff B., Layman M., Combs B. Judged frequency of lethal events. Journal of Experimental Psychology: Human Learning and Memory 1978, 4:551-578.
82. Litwin M.S., Gore J.L., Kwan L., Brandeis J.M., Lee S.P., Withers H.R., et al. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer 2007, 109(11):2239-2247.
83. Localio A.R., Lawthers A.G., Brennan T.A., Laird N.M., Hebert L.E., Peterson L.M., et al. Relation between malpractice claims and adverse events due to negligence. Results of the Harvard Medical Practice Study III. New England Journal of Medicine 1991, 325(4):245-251.
84. Lucas F.L., Sirovich B.E., Gallagher P.M., Siewers A.E., Wennberg D.E. Variation in cardiologists' propensity to test and treat: Is it associated with regional variation in utilization?. Circulation: Cardiovascular Quality and Outcomes 2010, 3(3):253-260.
85. Lurie N., Christianson J., Finch M., Moscovice I. The effects of capitation on health and functional status of the Medicaid elderly: A randomized trial. Annals of Internal Medicine 1994, 120:506-511.
86. Manning W.G., Newhouse J.P., Duan N., Keeler E., Leibowitz A., Marquis M.S. Health insurance and the demand for medical care: Results from a randomized experiment. American Economic Review 1987, 77(3, June):251-277.
87. Marshall, S., McGarry, K. M., & Skinner, J. S. (2010). The risk of out-of-pocket health care expenditure at end of life. NBER Working Paper No. 16170.
88. McClellan M. Reforming payments to healthcare providers: The key to slowing healthcare cost growth while improving quality?. Journal of Economic Perspectives 2011, 25(2):69-92.
89. McClellan M., Skinner J. The incidence of Medicare. Journal of Public Economics 2006, 90:257-276.
90. McGuire T.G. Physician agency. Handbook of health economics 2000, Elsevier, Amsterdam, (Chapter 9). A.J. Culyer, J.P. Newhouse (Eds.).
91. McGuire T.G., Pauly M.V. Physician response to fee changes with multiple payers. Journal of Health Economics 1991, 10(4):385-410.
92. McNeil B.J., Pauker S.G., Sox H.C., Tversky A. On the elicitation of preferences for alternative therapies. New England Journal of Medicine 1982, 306(21):1259-1262.
93. Mello M.M., Chandra A., Gawande A.A., Studdert D.M. National costs of the medical liability system. Health Affairs (Millwood) 2010, 29(9):1569-1577.
94. Miller R.H., Luft H.S. Managed care plan performance since 1980: A literature analysis. JAMA 1994, 271:1512-1519.
95. Myers D.G., Lamm H. The group polarization phenomenon. Psychological Bulletin 1976, 83:602-627.
96. National Comprehensive Cancer Network (2010). Prostate Cancer: NCCN Guidelines for Patients, version 2010. Accessed on June 7, 2011. http://www.nccn.com/images/patient-guidelines/pdf/prostate.pdf.
97. Newhouse J.P. Medicare care costs: How much welfare loss?. Journal of Economic Perspectives 1992, 6(3):3-21.
98. Newhouse J.P. Reconsidering the moral hazard-risk avoidance tradeoff. Journal of Health Economics 2006, 25(5):1005-1014.
99. Newhouse, J. P. & the Insurance Experiment Group (1993). Free for all Lessons from the RAND Health Insurance Experiment. Cambridge, MA: Harvard University Press.
100. Nguyen N.X., Derrick F.W. Physician behavioral response to a Medicare price reduction. Health Services Research 1997, 32:283-298.
101. O'Hare A.M., Rodriguez R.A., Hailpern S.M., Larson E.B., Kurella Tamura M. Regional variation in health care intensity and treatment practices for end-stage renal disease in older adults. JAMA 2010, 304(2):180-186.
102. Pauly M.V. The economics of moral hazard: Comment. American Economic Review 1968, 58(3):531-537.
103. Phelps C.E. Induced demand: Can we ever know its extent. Journal of Health Economics 1986, 5:355-365.
104. Potosky A.L., Legler J., Albertsen P.C., Stanford J.L., Gilliland F.D., Hamilton A.S., et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: Results from the Prostate Cancer Outcomes Study. Journal of the National Cancer Institute 2000, 92(19):1582-1592.
105. Pritchard R.S., Fisher E.S., Teno J.M., Sharp S.M., Reding D.J., Knaus W.A., et al. Influence of patient preferences and local health system characteristics on the place of death. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Risks and Outcomes of Treatment. Journal of the American Geriatric Society 1998, 46(10):1242-1250.
106. Redelmeier D.A., Tversky A. Discrepancy between medical decisions for individual patients and for groups. New England Journal of Medicine 1990, 322(16):1162-1164.
107. Reinhardt U.E. The economist's model of physician behavior. JAMA 1999, 281(5):462-465.
108. Rice T. The impact of changing Medicare reimbursement rates on physician-induced demand. Medical Care 1983, 21:803-815.
109. Rogers E.M. Diffusion of innovations 1983, Free Press, New York.
110. Rossiter L.F., Wilensky G.R. Identification of physician-induced demand. Journal of Human Resources 1984, 19:231-244.
111. Sanda M.G., Dunn R.L., Michalski J., Sandler H.M., Northouse L., Hembroff L., et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. New England Journal of Medicine 2008, 358(12):1250-1261.
112. Schelling T. Micromotives and macrobehavior 2006, W. W. Norton and Co.
113. Schröder F.H., Hugosson J., Roobol M.J., Tammela T.L., Ciatto S., Nelen V., et al. Screening and prostate-cancer mortality in a randomized European study. New England Journal of Medicine 2009, 360(13):1320-1328.
114. Sepucha K., Mulley A.G. A perspective on the patient's role in treatment decisions. Medical Care Research Review 2009, 66(Suppl. 1):53S-74S.
115. Shaneyfelt T.M., Mayo-Smith M.F., Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999, 281(20):1900-1905.
116. Shappley W.V., Kenfield S.A., Kasperzyk J.L., Qiu W., Stampfer M.J., Sanda M.G., et al. Prospective study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort. Journal of Clinical Oncology 2009, 27(30):4980-4985.
117. Shrank W.H., Choudhry N.K., Fischer M.A., Avorn J., Powell M., Schneeweiss S., et al. The epidemiology of prescriptions abandoned at the pharmacy. Annals of Internal Medicine 2010, 153(10):633-640.
118. Sirovich B., Gallagher P.M., Wennberg D.E., Fisher E.S. Discretionary decision making by primary care physicians and the cost of U.S. health care. Health Affairs (Millwood) 2008, 27(3):813-823.
119. Skinner, J. & Staiger, D. (2005). Technology adoption from hybrid corn to beta blockers. NBER Working Paper No. 11251.
120. Skinner, J. & Staiger, D. (2009). Technology diffusion and productivity growth in health care. NBER Working Paper No. 14865.
121. Smith D.M., Brown S.L., Ubel P.A. Are subjective well-being measures any better than decision utility measures?. Health Economics, Policy & Law 2008, 3(Pt 1):85-91.
122. Smith D.M., Sherriff R.L., Damschroder L., Loewenstein G., Ubel P.A. Misremembering colostomies? Former patients give lower utility ratings than do current patients. Health Psychology 2006, 25(6):688-695.
123. Smith M.R. Effective treatment for early-stage prostate cancer-possible, necessary, or both?. New England Journal of Medicine 2011, 364:1770-1772.
124. Snail T.S., Robinson J.C. Organization diversification in the American hospital. Annual Review of Public Health 1998, 19:417-453.
125. Sommers B.D., Zeckhauser R. Probabilities and preferences: What economics can teach doctors and patients making difficult treatment decisions. Urologic Oncology 2008, 26(6):669-673.
126. Sommers B.D., Beard C.J., D'Amico A.V., Kaplan I., Richie J.P., Zeckhauser R.J. Predictors of patient preferences and treatment choices for localized prostate cancer. Cancer 2008, 113(8):2058-2067.
127. Song Y., Skinner J., Bynum J., Sutherland J., Wennberg J.E., Fisher E.S. Regional variations in diagnostic practices. New England Journal of Medicine 2010, 363(1):45-53.
128. Steinhauser K.E., Christakis N.A., Clipp E.C., et al. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA 2000, 284:2476-2482.
129. Stewart S.T., Lenert L., Bhatnagar V., Kaplan R.M. Utilities for prostate cancer health states in men aged 60 and older. Medical Care 2005, 43(4):347-355.
130. Sutherland J.M., Fisher E.S., Skinner J.S. Getting past denial-the high cost of health care in the United States. New England Journal of Medicine 2009, 361(13):1227-1230.
131. Teno J.M., Licks S., Lynn J., et al. Do advance directives provide instructions that direct care?. Journal of the American Geriatric Society 1997, 45:508-512.
132. Thaler R.H., Sunstein C.R. Nudge 2008, Yale University Press, New Haven, CT.
133. Thompson I., Thrasher J.B., Aus G., Burnett A.L., Canby-Hagino E.D., Cookson M.S., et al. Guideline for the management of clinically localized prostate cancer: 2007 update. Journal of Urology 2007, 177(6):2106.
134. Tricoci P., Allen J.M., Kramer J.M., Califf R.M., Smith S.C. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009, 301(8):831-841.
135. Trivedi A.N., Moloo H., Mor V. Increased ambulatory care copayments and hospitalizations among the elderly. New England Journal of Medicine 2010, 362(4):320-328.
136. Ubel P.A. Free market madness 2009, Harvard Business Press, Boston, MA.
137. Ubel P.A., Loewenstein G., Schwarz N., Smith D. Misimagining the unimaginable: The disability paradox and health care decision making. Health Psychology 2005, 24(Suppl. 4):S57-S62.
138. Van Heek N.T., Kuhlmann K.F., Scholten R.J., de Castro S.M., Busch O.R., van Gulik T.M., et al. Hospital volume and mortality after pancreatic resection: A systematic review and an evaluation of intervention in the Netherlands. Annals of Surgery 2005, 242(6):781-788.
139. Wei J.T., Dunn R.L., Sandler H.M., McLaughlin P.W., Montie J.E., Litwin M.S., et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. Journal of Clinical Oncology 2002, 20(2):557-566.
140. Weintraub W.S., Spertus J.A., Kolm P., et al. Effect of PCI on quality of life in patients with stable coronary disease. New England Journal of Medicine 2008, 359(7):677-687.
141. Welch H.G., Sharp S.M., Gottlieb D.J., Skinner J.S., Wennberg J.E. Geographic variation in diagnosis frequency and risk of death among Medicare beneficiaries. JAMA 2011, 305(11):1113-1118.
142. Wennberg J., Gittelsohn A. Small area variations in health care delivery. Science 1973, 182(117):1102-1108.
143. Wennberg J., Gittelsohn A. Variations in medical care among small areas. Scientific American 1982, 246(4):120-134.
144. Wennberg J.E., Freeman J.L., Culp W.J. Are hospital services rationed in New Haven or over-utilised in Boston?. Lancet 1987, 1(8543):1185-1189.
145. Williamson O.E. Transaction cost economics: The natural progression. American Economic Review 2010, 100:673-690.
146. Wilt T.J., MacDonald R., Rutks I., Shamliyan T.A., Taylor B.C., Kane R.L. Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer. Annals of Internal Medicine 2008, 148(6):435-448.
147. Woo B., Woo B., Cook E.F., Weisberg M., Goldman L. Screening procedures in the asymptomatic adult. Comparison of physicians' recommendations, patients' desires, published guidelines, and actual practice. JAMA 1985, 254(11):1480-1484.
148. Yip W. Physician responses to medical fee reductions: Changes in the volume and intensity of supply of Coronary Artery Bypass Graft (CABG) surgeries in the Medicare and private sectors. Journal of Health Economics 1998, 17:675-700.
149. Young H.P. Individual strategy and social structure: An evolutionary theory of institutions 1998, Princeton University Press, Princeton, NJ.
150. Zeckhauser R.J. Medical insurance: A case study of the tradeoff between risk spreading and appropriate incentives. Journal of Economic Theory 1970, 2(1):10-26.
151. Zuckerman S., Waidmann T., Berenson R., Hadley J. Clarifying sources of geographic differences in Medicare spending. New England Journal of Medicine 2010, 363(1):54-62.